Head: Priv.-Doz. Dr. med. Jürgen Rech
Controlled clinical studies are necessary to evaluate the effectiveness and quality of new drugs/medications. These studies enable us to offer innovative therapeutic methods and close monitoring of application under optimal conditions.
Actually, due to an insufficient response of your previous therapy against diseases as Rheumatoid arthritis, Psoriasis Arthritis, Morbus Behcet, giant cell arteritis or Scleroderma, we can offer you promising aternatives of therapies in different dosage forms (tablettes, subcutaneous administration respectively infusion).
The clinical trial unit of the Department of Internal Medicine 3 performs several international, multicenter trial of phases II to IV for tratment of rheumatic inflammatory diseases. The unit is spartial and personnel operating independently driectly linked to the structure of supply of the university hospital. This embedding as well the special education and long-standing experiences of our staff guarantee high level quality standards.